Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

GlucoTrack, Inc. (GCTK) stock profile

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for people with diabetes and pre-diabetes in Israel and internationally. It develops the GlucoTrack glucose monitoring device, which enables people with diabetes and pre-diabetes to obtain blood glucose level readings without pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

Key facts

SymbolGCTK
ExchangeNASDAQ
SectorHealthcare
IndustryMedical - Instruments & Supplies
CEOPaul V. Goode
Employees11
HeadquartersOr Yehuda, IL
IPO2013-04-25
Websitewww.glucotrack.com

Explore GCTK on Vantafin

  • GlucoTrack, Inc. Overview
  • GlucoTrack, Inc. Financials
  • GlucoTrack, Inc. News
  • GlucoTrack, Inc. Events
  • GlucoTrack, Inc. SEC filings
  • GlucoTrack, Inc. Insider transactions

Frequently asked questions

What does GlucoTrack, Inc. (GCTK) do?
GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for people with diabetes and pre-diabetes in Israel and internationally. It develops the GlucoTrack glucose monitoring device, which enables people with diabetes and pre-diabetes to obtain blood glucose level readings without pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.
Where is GCTK stock listed?
GlucoTrack, Inc. trades under the ticker GCTK on NASDAQ.
How can I research GCTK's financials and filings?
Vantafin provides GlucoTrack, Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the GCTK profile.